These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31156814)

  • 1. Aseptic preparation of parenteral medicinal products in healthcare establishments in Europe.
    Scheepers H; Beaney AM; Le Brun P; Neerup Handlos V; Schutjens M; Walser S; Neef C
    Eur J Hosp Pharm; 2016 Jan; 23(1):50-53. PubMed ID: 31156814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Council of Europe Resolution CM/Res(2016)2: a major contribution to patient safety from reconstituted injectable medicines?
    Beaney AM; Le Brun P; Ravera S; Scheepers H
    Eur J Hosp Pharm; 2020 Jul; 27(4):216-221. PubMed ID: 32587080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the Council of Europe Resolution on quality and safety assurance requirements for medicinal products prepared in pharmacies for the special needs of patients.
    Scheepers HPA; Neerup Handlos V; Walser S; Schutjens MDB; Neef C
    Eur J Hosp Pharm; 2017 Jul; 24(4):218-223. PubMed ID: 31157793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Legislation on the preparation of medicinal products in European pharmacies and the Council of Europe Resolution.
    Scheepers HP; Langedijk J; Neerup Handlos V; Walser S; Schutjens MH; Neef C
    Eur J Hosp Pharm; 2017 Jul; 24(4):224-229. PubMed ID: 31157801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory framework of pharmaceutical compounding and actual developments of legislation in Europe.
    Minghetti P; Pantano D; Gennari CG; Casiraghi A
    Health Policy; 2014 Sep; 117(3):328-33. PubMed ID: 25110297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Outlook on the European and Italian Rules to Guarantee Magistral Formulas.
    Selmin F; Casiraghi A; Musazzi UM; Fortini M; Minghetti P
    Int J Pharm Compd; 2019; 23(1):6-12. PubMed ID: 30668530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The legal framework governing the quality of (traditional) herbal medicinal products in the European Union.
    Kroes BH
    J Ethnopharmacol; 2014 Dec; 158 Pt B():449-53. PubMed ID: 25086408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical counseling: Between evidence-based medicine and profits.
    Egorova SN; Akhmetova T
    Int J Risk Saf Med; 2015; 27 Suppl 1():S87-8. PubMed ID: 26639727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient safety issues associated with the use of compounded medicines as alternatives to approved pharmaceutical products in Europe and how best practice can improve outcomes.
    Isles M
    Int J Risk Saf Med; 2020; 31(3):133-144. PubMed ID: 32538874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical Regulatory Framework in Ethiopia: A Critical Evaluation of Its Legal Basis and Implementation.
    Suleman S; Woliyi A; Woldemichael K; Tushune K; Duchateau L; Degroote A; Vancauwenberghe R; Bracke N; De Spiegeleer B
    Ethiop J Health Sci; 2016 May; 26(3):259-76. PubMed ID: 27358547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorrect aseptic techniques in medicine preparation and recommendations for safer practices: a systematic review.
    Suvikas-Peltonen E; Hakoinen S; Celikkayalar E; Laaksonen R; Airaksinen M
    Eur J Hosp Pharm; 2017 May; 24(3):175-181. PubMed ID: 31156932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are UK hospital pharmacy departments ready for the rise of gene therapy medicinal products?
    Stoner N
    Expert Opin Biol Ther; 2018 Aug; 18(8):837-840. PubMed ID: 29962243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of parenteral medicines in clinical areas: how can the risks be managed - a UK perspective?
    Beaney AM
    J Clin Nurs; 2010 Jun; 19(11-12):1569-77. PubMed ID: 20579198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The European Herbal Medicines Directive: could it have saved the lives of Romeo and Juliet?
    Routledge PA
    Drug Saf; 2008; 31(5):416-8. PubMed ID: 18422382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National survey of quality assurance activities for pharmacy-prepared sterile products in hospitals.
    Crawford SY; Narducci WA; Augustine SC
    Am J Hosp Pharm; 1991 Nov; 48(11):2398-413. PubMed ID: 1746573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Extent of Extemporaneous Preparation and Regulatory Framework of Extemporaneous Compounding in Latvia.
    Kiseļova O; Mauriņa B; Šidlovska V; Zvejnieks J
    Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31454896
    [No Abstract]   [Full Text] [Related]  

  • 19. Collaborative study for the establishment of the WHO 3(rd) International Standard for Endotoxin, the Ph. Eur. endotoxin biological reference preparation batch 5 and the USP Reference Standard for Endotoxin Lot H0K354.
    Findlay L; Desai T; Heath A; Poole S; Crivellone M; Hauck W; Ambrose M; Morris T; Daas A; Rautmann G; Buchheit KH; Spieser JM; Terao E
    Pharmeur Bio Sci Notes; 2015; 2015():73-98. PubMed ID: 26830160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granting marketing authorisation for medicines in South East European countries: the point of view of the authority.
    Tomić S; Sucić AF; Martinac AI
    Regul Toxicol Pharmacol; 2010; 57(2-3):325-32. PubMed ID: 20385190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.